nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—DHFR—Methotrexate—psoriasis	0.192	0.236	CbGbCtD
Proguanil—CYP1A2—Clobetasol propionate—psoriasis	0.0972	0.119	CbGbCtD
Proguanil—CYP1A2—Methoxsalen—psoriasis	0.0511	0.0626	CbGbCtD
Proguanil—CYP2D6—Hydroxyurea—psoriasis	0.046	0.0564	CbGbCtD
Proguanil—CYP2C19—Cholecalciferol—psoriasis	0.0367	0.045	CbGbCtD
Proguanil—CYP3A4—Calcitriol—psoriasis	0.0344	0.0422	CbGbCtD
Proguanil—CYP2C9—Cholecalciferol—psoriasis	0.0305	0.0374	CbGbCtD
Proguanil—CYP2D6—Cholecalciferol—psoriasis	0.0279	0.0342	CbGbCtD
Proguanil—CYP3A4—Methoxsalen—psoriasis	0.0268	0.0328	CbGbCtD
Proguanil—CYP2C19—Prednisone—psoriasis	0.0254	0.0312	CbGbCtD
Proguanil—CYP2E1—Dexamethasone—psoriasis	0.0253	0.031	CbGbCtD
Proguanil—CYP2C19—Cyclosporine—psoriasis	0.0241	0.0295	CbGbCtD
Proguanil—CYP2C9—Cyclosporine—psoriasis	0.02	0.0246	CbGbCtD
Proguanil—CYP2D6—Cyclosporine—psoriasis	0.0183	0.0225	CbGbCtD
Proguanil—CYP3A4—Cholecalciferol—psoriasis	0.0177	0.0217	CbGbCtD
Proguanil—CYP2C19—Dexamethasone—psoriasis	0.0159	0.0195	CbGbCtD
Proguanil—CYP3A4—Triamcinolone—psoriasis	0.0154	0.0188	CbGbCtD
Proguanil—CYP3A4—Mycophenolate mofetil—psoriasis	0.0154	0.0188	CbGbCtD
Proguanil—CYP2C9—Dexamethasone—psoriasis	0.0132	0.0162	CbGbCtD
Proguanil—CYP3A4—Betamethasone—psoriasis	0.0132	0.0162	CbGbCtD
Proguanil—CYP3A4—Prednisolone—psoriasis	0.013	0.0159	CbGbCtD
Proguanil—CYP3A4—Hydrocortisone—psoriasis	0.0123	0.0151	CbGbCtD
Proguanil—CYP3A4—Prednisone—psoriasis	0.0123	0.0151	CbGbCtD
Proguanil—CYP2D6—Dexamethasone—psoriasis	0.0121	0.0148	CbGbCtD
Proguanil—CYP3A4—Cyclosporine—psoriasis	0.0116	0.0143	CbGbCtD
Proguanil—CYP3A4—Dexamethasone—psoriasis	0.00767	0.0094	CbGbCtD
Proguanil—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00262	0.0653	CbGpPWpGaD
Proguanil—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00202	0.0504	CbGpPWpGaD
Proguanil—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00186	0.0463	CbGpPWpGaD
Proguanil—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00185	0.0459	CbGpPWpGaD
Proguanil—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00174	0.0432	CbGpPWpGaD
Proguanil—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00163	0.0405	CbGpPWpGaD
Proguanil—DHFR—G1/S-Specific Transcription—PCNA—psoriasis	0.00134	0.0334	CbGpPWpGaD
Proguanil—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00125	0.0312	CbGpPWpGaD
Proguanil—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.00115	0.0287	CbGpPWpGaD
Proguanil—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00114	0.0285	CbGpPWpGaD
Proguanil—Immune system disorder—Acitretin—psoriasis	0.00101	0.00697	CcSEcCtD
Proguanil—Mediastinal disorder—Fluocinolone Acetonide—psoriasis	0.001	0.00693	CcSEcCtD
Proguanil—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000977	0.0243	CbGpPWpGaD
Proguanil—Mental disorder—Fluocinolone Acetonide—psoriasis	0.000973	0.00674	CcSEcCtD
Proguanil—Erythema—Acitretin—psoriasis	0.000969	0.00671	CcSEcCtD
Proguanil—Skin disorder—Methoxsalen—psoriasis	0.000969	0.00671	CcSEcCtD
Proguanil—Erythema—Fluocinolone Acetonide—psoriasis	0.000967	0.0067	CcSEcCtD
Proguanil—Malnutrition—Fluocinolone Acetonide—psoriasis	0.000967	0.0067	CcSEcCtD
Proguanil—Stomatitis—Hydroxyurea—psoriasis	0.000949	0.00658	CcSEcCtD
Proguanil—Hepatobiliary disease—Hydroxyurea—psoriasis	0.000921	0.00638	CcSEcCtD
Proguanil—Rash—Clobetasol propionate—psoriasis	0.000883	0.00612	CcSEcCtD
Proguanil—Dermatitis—Clobetasol propionate—psoriasis	0.000883	0.00611	CcSEcCtD
Proguanil—Headache—Clobetasol propionate—psoriasis	0.000878	0.00608	CcSEcCtD
Proguanil—Hallucination—Hydroxyurea—psoriasis	0.00087	0.00603	CcSEcCtD
Proguanil—Pancytopenia—Mycophenolic acid—psoriasis	0.000869	0.00602	CcSEcCtD
Proguanil—Skin disorder—Calcitriol—psoriasis	0.000864	0.00598	CcSEcCtD
Proguanil—Gastrointestinal disorder—Methoxsalen—psoriasis	0.000861	0.00597	CcSEcCtD
Proguanil—Anorexia—Calcitriol—psoriasis	0.000848	0.00587	CcSEcCtD
Proguanil—Cough—Acitretin—psoriasis	0.000846	0.00586	CcSEcCtD
Proguanil—Cough—Fluocinolone Acetonide—psoriasis	0.000843	0.00584	CcSEcCtD
Proguanil—Rash—Beclomethasone—psoriasis	0.000804	0.00557	CcSEcCtD
Proguanil—Dermatitis—Beclomethasone—psoriasis	0.000804	0.00557	CcSEcCtD
Proguanil—Headache—Beclomethasone—psoriasis	0.000799	0.00554	CcSEcCtD
Proguanil—Rash—Fluocinonide—psoriasis	0.000797	0.00552	CcSEcCtD
Proguanil—Dermatitis—Fluocinonide—psoriasis	0.000796	0.00552	CcSEcCtD
Proguanil—Stomatitis—Mycophenolic acid—psoriasis	0.000795	0.00551	CcSEcCtD
Proguanil—Headache—Fluocinonide—psoriasis	0.000792	0.00549	CcSEcCtD
Proguanil—Body temperature increased—Methoxsalen—psoriasis	0.000789	0.00546	CcSEcCtD
Proguanil—DHFR—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000789	0.0196	CbGpPWpGaD
Proguanil—Nervous system disorder—Fluocinolone Acetonide—psoriasis	0.000774	0.00536	CcSEcCtD
Proguanil—Decreased appetite—Calcitriol—psoriasis	0.000773	0.00535	CcSEcCtD
Proguanil—Hepatobiliary disease—Mycophenolic acid—psoriasis	0.000771	0.00534	CcSEcCtD
Proguanil—Skin disorder—Acitretin—psoriasis	0.000768	0.00532	CcSEcCtD
Proguanil—Erythema—Hydroxyurea—psoriasis	0.000761	0.00527	CcSEcCtD
Proguanil—Nausea—Beclomethasone—psoriasis	0.000758	0.00525	CcSEcCtD
Proguanil—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000754	0.0188	CbGpPWpGaD
Proguanil—Anorexia—Acitretin—psoriasis	0.000754	0.00522	CcSEcCtD
Proguanil—Hallucination—Mycophenolic acid—psoriasis	0.000728	0.00505	CcSEcCtD
Proguanil—Gastrointestinal pain—Calcitriol—psoriasis	0.000727	0.00504	CcSEcCtD
Proguanil—Abdominal pain—Calcitriol—psoriasis	0.000703	0.00487	CcSEcCtD
Proguanil—Body temperature increased—Calcitriol—psoriasis	0.000703	0.00487	CcSEcCtD
Proguanil—Hepatic enzyme increased—Methotrexate—psoriasis	0.000689	0.00477	CcSEcCtD
Proguanil—Decreased appetite—Acitretin—psoriasis	0.000688	0.00476	CcSEcCtD
Proguanil—Pancytopenia—Mycophenolate mofetil—psoriasis	0.000686	0.00475	CcSEcCtD
Proguanil—Gastrointestinal disorder—Acitretin—psoriasis	0.000683	0.00473	CcSEcCtD
Proguanil—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000681	0.00472	CcSEcCtD
Proguanil—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000675	0.0168	CbGpPWpGaD
Proguanil—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000666	0.0166	CbGpPWpGaD
Proguanil—Mediastinal disorder—Mycophenolic acid—psoriasis	0.00066	0.00457	CcSEcCtD
Proguanil—Gastrointestinal pain—Acitretin—psoriasis	0.000647	0.00448	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.000643	0.00446	CcSEcCtD
Proguanil—Stomatitis—Cyclosporine—psoriasis	0.000643	0.00446	CcSEcCtD
Proguanil—Mental disorder—Mycophenolic acid—psoriasis	0.000641	0.00444	CcSEcCtD
Proguanil—Malnutrition—Mycophenolic acid—psoriasis	0.000637	0.00442	CcSEcCtD
Proguanil—Rash—Methoxsalen—psoriasis	0.000629	0.00436	CcSEcCtD
Proguanil—Dermatitis—Methoxsalen—psoriasis	0.000628	0.00435	CcSEcCtD
Proguanil—Stomatitis—Mycophenolate mofetil—psoriasis	0.000627	0.00435	CcSEcCtD
Proguanil—Abdominal pain—Acitretin—psoriasis	0.000625	0.00433	CcSEcCtD
Proguanil—Body temperature increased—Acitretin—psoriasis	0.000625	0.00433	CcSEcCtD
Proguanil—Headache—Methoxsalen—psoriasis	0.000625	0.00433	CcSEcCtD
Proguanil—Hepatobiliary disease—Cyclosporine—psoriasis	0.000624	0.00432	CcSEcCtD
Proguanil—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000624	0.00432	CcSEcCtD
Proguanil—Nervous system disorder—Hydroxyurea—psoriasis	0.000609	0.00422	CcSEcCtD
Proguanil—Hepatobiliary disease—Mycophenolate mofetil—psoriasis	0.000609	0.00422	CcSEcCtD
Proguanil—Diarrhoea—Calcitriol—psoriasis	0.000608	0.00421	CcSEcCtD
Proguanil—Skin disorder—Hydroxyurea—psoriasis	0.000603	0.00418	CcSEcCtD
Proguanil—Nausea—Methoxsalen—psoriasis	0.000593	0.00411	CcSEcCtD
Proguanil—Anorexia—Hydroxyurea—psoriasis	0.000592	0.0041	CcSEcCtD
Proguanil—Hallucination—Mycophenolate mofetil—psoriasis	0.000575	0.00398	CcSEcCtD
Proguanil—Vomiting—Calcitriol—psoriasis	0.000565	0.00392	CcSEcCtD
Proguanil—Rash—Calcitriol—psoriasis	0.000561	0.00388	CcSEcCtD
Proguanil—Dermatitis—Calcitriol—psoriasis	0.00056	0.00388	CcSEcCtD
Proguanil—Headache—Calcitriol—psoriasis	0.000557	0.00386	CcSEcCtD
Proguanil—Cough—Mycophenolic acid—psoriasis	0.000556	0.00385	CcSEcCtD
Proguanil—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000547	0.0136	CbGpPWpGaD
Proguanil—Diarrhoea—Acitretin—psoriasis	0.000541	0.00375	CcSEcCtD
Proguanil—Decreased appetite—Hydroxyurea—psoriasis	0.00054	0.00374	CcSEcCtD
Proguanil—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.00054	0.00374	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000539	0.00373	CcSEcCtD
Proguanil—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000536	0.00371	CcSEcCtD
Proguanil—Mediastinal disorder—Cyclosporine—psoriasis	0.000534	0.0037	CcSEcCtD
Proguanil—Nausea—Calcitriol—psoriasis	0.000528	0.00366	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—CAT—psoriasis	0.000526	0.0131	CbGpPWpGaD
Proguanil—Hallucination—Hydrocortisone—psoriasis	0.000524	0.00363	CcSEcCtD
Proguanil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000521	0.013	CbGpPWpGaD
Proguanil—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.000521	0.00361	CcSEcCtD
Proguanil—Mental disorder—Cyclosporine—psoriasis	0.000519	0.00359	CcSEcCtD
Proguanil—Malnutrition—Cyclosporine—psoriasis	0.000516	0.00357	CcSEcCtD
Proguanil—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000514	0.0128	CbGpPWpGaD
Proguanil—Nervous system disorder—Mycophenolic acid—psoriasis	0.00051	0.00353	CcSEcCtD
Proguanil—Mental disorder—Mycophenolate mofetil—psoriasis	0.000506	0.00351	CcSEcCtD
Proguanil—Skin disorder—Mycophenolic acid—psoriasis	0.000505	0.0035	CcSEcCtD
Proguanil—Malnutrition—Mycophenolate mofetil—psoriasis	0.000503	0.00348	CcSEcCtD
Proguanil—Vomiting—Acitretin—psoriasis	0.000503	0.00348	CcSEcCtD
Proguanil—Vomiting—Fluocinolone Acetonide—psoriasis	0.000502	0.00347	CcSEcCtD
Proguanil—Rash—Acitretin—psoriasis	0.000499	0.00346	CcSEcCtD
Proguanil—Dermatitis—Acitretin—psoriasis	0.000498	0.00345	CcSEcCtD
Proguanil—Rash—Fluocinolone Acetonide—psoriasis	0.000497	0.00345	CcSEcCtD
Proguanil—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000497	0.00344	CcSEcCtD
Proguanil—Anorexia—Mycophenolic acid—psoriasis	0.000496	0.00343	CcSEcCtD
Proguanil—Headache—Acitretin—psoriasis	0.000496	0.00343	CcSEcCtD
Proguanil—Headache—Fluocinolone Acetonide—psoriasis	0.000494	0.00342	CcSEcCtD
Proguanil—Body temperature increased—Hydroxyurea—psoriasis	0.000491	0.0034	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—IL4—psoriasis	0.000483	0.012	CbGpPWpGaD
Proguanil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000479	0.0119	CbGpPWpGaD
Proguanil—Immune system disorder—Hydrocortisone—psoriasis	0.000475	0.00329	CcSEcCtD
Proguanil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000475	0.0118	CbGpPWpGaD
Proguanil—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000473	0.0118	CbGpPWpGaD
Proguanil—Nausea—Acitretin—psoriasis	0.00047	0.00325	CcSEcCtD
Proguanil—Erythema—Prednisolone—psoriasis	0.000469	0.00325	CcSEcCtD
Proguanil—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000469	0.0117	CbGpPWpGaD
Proguanil—Nausea—Fluocinolone Acetonide—psoriasis	0.000469	0.00325	CcSEcCtD
Proguanil—Mental disorder—Hydrocortisone—psoriasis	0.000461	0.00319	CcSEcCtD
Proguanil—Malnutrition—Hydrocortisone—psoriasis	0.000458	0.00317	CcSEcCtD
Proguanil—Erythema—Hydrocortisone—psoriasis	0.000458	0.00317	CcSEcCtD
Proguanil—Decreased appetite—Mycophenolic acid—psoriasis	0.000452	0.00313	CcSEcCtD
Proguanil—Cough—Cyclosporine—psoriasis	0.00045	0.00312	CcSEcCtD
Proguanil—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000449	0.00311	CcSEcCtD
Proguanil—Hallucination—Dexamethasone—psoriasis	0.000447	0.0031	CcSEcCtD
Proguanil—Hallucination—Betamethasone—psoriasis	0.000447	0.0031	CcSEcCtD
Proguanil—Cough—Mycophenolate mofetil—psoriasis	0.000439	0.00304	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000436	0.00302	CcSEcCtD
Proguanil—Erythema—Triamcinolone—psoriasis	0.000431	0.00299	CcSEcCtD
Proguanil—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000425	0.00295	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000425	0.00295	CcSEcCtD
Proguanil—Diarrhoea—Hydroxyurea—psoriasis	0.000425	0.00294	CcSEcCtD
Proguanil—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000422	0.0105	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—CRP—psoriasis	0.000417	0.0104	CbGpPWpGaD
Proguanil—Nervous system disorder—Cyclosporine—psoriasis	0.000413	0.00286	CcSEcCtD
Proguanil—Body temperature increased—Mycophenolic acid—psoriasis	0.000411	0.00285	CcSEcCtD
Proguanil—Abdominal pain—Mycophenolic acid—psoriasis	0.000411	0.00285	CcSEcCtD
Proguanil—Skin disorder—Cyclosporine—psoriasis	0.000409	0.00283	CcSEcCtD
Proguanil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000406	0.0101	CbGpPWpGaD
Proguanil—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000403	0.00279	CcSEcCtD
Proguanil—Anorexia—Cyclosporine—psoriasis	0.000401	0.00278	CcSEcCtD
Proguanil—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000401	0.00997	CbGpPWpGaD
Proguanil—Skin disorder—Mycophenolate mofetil—psoriasis	0.000399	0.00276	CcSEcCtD
Proguanil—Vomiting—Hydroxyurea—psoriasis	0.000395	0.00274	CcSEcCtD
Proguanil—Rash—Hydroxyurea—psoriasis	0.000392	0.00271	CcSEcCtD
Proguanil—Erythema—Betamethasone—psoriasis	0.000391	0.00271	CcSEcCtD
Proguanil—Erythema—Dexamethasone—psoriasis	0.000391	0.00271	CcSEcCtD
Proguanil—Anorexia—Mycophenolate mofetil—psoriasis	0.000391	0.00271	CcSEcCtD
Proguanil—Dermatitis—Hydroxyurea—psoriasis	0.000391	0.00271	CcSEcCtD
Proguanil—Hallucination—Prednisone—psoriasis	0.00039	0.0027	CcSEcCtD
Proguanil—Headache—Hydroxyurea—psoriasis	0.000389	0.0027	CcSEcCtD
Proguanil—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000388	0.00966	CbGpPWpGaD
Proguanil—Pancytopenia—Methotrexate—psoriasis	0.000388	0.00269	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000387	0.00268	CcSEcCtD
Proguanil—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000385	0.00958	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—ICAM1—psoriasis	0.000384	0.00954	CbGpPWpGaD
Proguanil—Cough—Triamcinolone—psoriasis	0.000376	0.00261	CcSEcCtD
Proguanil—Nausea—Hydroxyurea—psoriasis	0.000369	0.00256	CcSEcCtD
Proguanil—Nervous system disorder—Hydrocortisone—psoriasis	0.000367	0.00254	CcSEcCtD
Proguanil—Decreased appetite—Cyclosporine—psoriasis	0.000366	0.00253	CcSEcCtD
Proguanil—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000363	0.00252	CcSEcCtD
Proguanil—Skin disorder—Hydrocortisone—psoriasis	0.000363	0.00252	CcSEcCtD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000363	0.00904	CbGpPWpGaD
Proguanil—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000357	0.00247	CcSEcCtD
Proguanil—Anorexia—Hydrocortisone—psoriasis	0.000356	0.00247	CcSEcCtD
Proguanil—Diarrhoea—Mycophenolic acid—psoriasis	0.000356	0.00247	CcSEcCtD
Proguanil—Stomatitis—Methotrexate—psoriasis	0.000355	0.00246	CcSEcCtD
Proguanil—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000354	0.00246	CcSEcCtD
Proguanil—Immune system disorder—Prednisone—psoriasis	0.000354	0.00245	CcSEcCtD
Proguanil—Hepatobiliary disease—Methotrexate—psoriasis	0.000345	0.00239	CcSEcCtD
Proguanil—Gastrointestinal pain—Cyclosporine—psoriasis	0.000344	0.00238	CcSEcCtD
Proguanil—Mental disorder—Prednisone—psoriasis	0.000343	0.00238	CcSEcCtD
Proguanil—Erythema—Prednisone—psoriasis	0.000341	0.00236	CcSEcCtD
Proguanil—Malnutrition—Prednisone—psoriasis	0.000341	0.00236	CcSEcCtD
Proguanil—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000336	0.00233	CcSEcCtD
Proguanil—Body temperature increased—Cyclosporine—psoriasis	0.000333	0.0023	CcSEcCtD
Proguanil—Abdominal pain—Cyclosporine—psoriasis	0.000333	0.0023	CcSEcCtD
Proguanil—Vomiting—Mycophenolic acid—psoriasis	0.000331	0.00229	CcSEcCtD
Proguanil—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000329	0.00819	CbGpPWpGaD
Proguanil—Rash—Mycophenolic acid—psoriasis	0.000328	0.00227	CcSEcCtD
Proguanil—Dermatitis—Mycophenolic acid—psoriasis	0.000328	0.00227	CcSEcCtD
Proguanil—Headache—Mycophenolic acid—psoriasis	0.000326	0.00226	CcSEcCtD
Proguanil—Decreased appetite—Hydrocortisone—psoriasis	0.000325	0.00225	CcSEcCtD
Proguanil—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000324	0.00225	CcSEcCtD
Proguanil—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000324	0.00225	CcSEcCtD
Proguanil—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000323	0.00224	CcSEcCtD
Proguanil—Nervous system disorder—Dexamethasone—psoriasis	0.000313	0.00217	CcSEcCtD
Proguanil—Nervous system disorder—Betamethasone—psoriasis	0.000313	0.00217	CcSEcCtD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000313	0.00779	CbGpPWpGaD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00031	0.00772	CbGpPWpGaD
Proguanil—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000309	0.00769	CbGpPWpGaD
Proguanil—Nausea—Mycophenolic acid—psoriasis	0.000309	0.00214	CcSEcCtD
Proguanil—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000306	0.00212	CcSEcCtD
Proguanil—Anorexia—Betamethasone—psoriasis	0.000305	0.00211	CcSEcCtD
Proguanil—Anorexia—Dexamethasone—psoriasis	0.000305	0.00211	CcSEcCtD
Proguanil—DHFR—G1/S Transition—PCNA—psoriasis	0.000303	0.00754	CbGpPWpGaD
Proguanil—Immune system disorder—Methotrexate—psoriasis	0.000296	0.00205	CcSEcCtD
Proguanil—Body temperature increased—Hydrocortisone—psoriasis	0.000296	0.00205	CcSEcCtD
Proguanil—Abdominal pain—Hydrocortisone—psoriasis	0.000296	0.00205	CcSEcCtD
Proguanil—Mediastinal disorder—Methotrexate—psoriasis	0.000295	0.00204	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—IFNG—psoriasis	0.000292	0.00726	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000291	0.00723	CbGpPWpGaD
Proguanil—DHFR—Fluoropyrimidine Activity—TP53—psoriasis	0.00029	0.00721	CbGpPWpGaD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000288	0.002	CcSEcCtD
Proguanil—Diarrhoea—Cyclosporine—psoriasis	0.000288	0.00199	CcSEcCtD
Proguanil—Mental disorder—Methotrexate—psoriasis	0.000287	0.00199	CcSEcCtD
Proguanil—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000287	0.00713	CbGpPWpGaD
Proguanil—Erythema—Methotrexate—psoriasis	0.000285	0.00197	CcSEcCtD
Proguanil—Malnutrition—Methotrexate—psoriasis	0.000285	0.00197	CcSEcCtD
Proguanil—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000281	0.00195	CcSEcCtD
Proguanil—Body temperature increased—Triamcinolone—psoriasis	0.000278	0.00193	CcSEcCtD
Proguanil—Decreased appetite—Dexamethasone—psoriasis	0.000278	0.00192	CcSEcCtD
Proguanil—Decreased appetite—Betamethasone—psoriasis	0.000278	0.00192	CcSEcCtD
Proguanil—Gastrointestinal disorder—Betamethasone—psoriasis	0.000276	0.00191	CcSEcCtD
Proguanil—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000276	0.00191	CcSEcCtD
Proguanil—Nervous system disorder—Prednisone—psoriasis	0.000273	0.00189	CcSEcCtD
Proguanil—Skin disorder—Prednisone—psoriasis	0.00027	0.00187	CcSEcCtD
Proguanil—Vomiting—Cyclosporine—psoriasis	0.000268	0.00185	CcSEcCtD
Proguanil—Rash—Cyclosporine—psoriasis	0.000265	0.00184	CcSEcCtD
Proguanil—Anorexia—Prednisone—psoriasis	0.000265	0.00184	CcSEcCtD
Proguanil—Dermatitis—Cyclosporine—psoriasis	0.000265	0.00184	CcSEcCtD
Proguanil—Headache—Cyclosporine—psoriasis	0.000264	0.00183	CcSEcCtD
Proguanil—Gastrointestinal pain—Betamethasone—psoriasis	0.000261	0.00181	CcSEcCtD
Proguanil—Gastrointestinal pain—Dexamethasone—psoriasis	0.000261	0.00181	CcSEcCtD
Proguanil—Vomiting—Mycophenolate mofetil—psoriasis	0.000261	0.00181	CcSEcCtD
Proguanil—Rash—Mycophenolate mofetil—psoriasis	0.000259	0.00179	CcSEcCtD
Proguanil—Dermatitis—Mycophenolate mofetil—psoriasis	0.000259	0.00179	CcSEcCtD
Proguanil—Headache—Mycophenolate mofetil—psoriasis	0.000257	0.00178	CcSEcCtD
Proguanil—Diarrhoea—Hydrocortisone—psoriasis	0.000256	0.00177	CcSEcCtD
Proguanil—DHFR—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000256	0.00636	CbGpPWpGaD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000254	0.00632	CbGpPWpGaD
Proguanil—Abdominal pain—Betamethasone—psoriasis	0.000253	0.00175	CcSEcCtD
Proguanil—Abdominal pain—Dexamethasone—psoriasis	0.000253	0.00175	CcSEcCtD
Proguanil—Body temperature increased—Dexamethasone—psoriasis	0.000253	0.00175	CcSEcCtD
Proguanil—Body temperature increased—Betamethasone—psoriasis	0.000253	0.00175	CcSEcCtD
Proguanil—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000251	0.00624	CbGpPWpGaD
Proguanil—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000251	0.00623	CbGpPWpGaD
Proguanil—Nausea—Cyclosporine—psoriasis	0.00025	0.00173	CcSEcCtD
Proguanil—Cough—Methotrexate—psoriasis	0.000249	0.00172	CcSEcCtD
Proguanil—Nausea—Mycophenolate mofetil—psoriasis	0.000244	0.00169	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—NFKB1—psoriasis	0.000243	0.00604	CbGpPWpGaD
Proguanil—Decreased appetite—Prednisone—psoriasis	0.000242	0.00168	CcSEcCtD
Proguanil—Rash—Prednisolone—psoriasis	0.000241	0.00167	CcSEcCtD
Proguanil—Dermatitis—Prednisolone—psoriasis	0.000241	0.00167	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000241	0.00167	CcSEcCtD
Proguanil—Headache—Prednisolone—psoriasis	0.00024	0.00166	CcSEcCtD
Proguanil—Vomiting—Hydrocortisone—psoriasis	0.000238	0.00165	CcSEcCtD
Proguanil—Rash—Hydrocortisone—psoriasis	0.000236	0.00163	CcSEcCtD
Proguanil—Dermatitis—Hydrocortisone—psoriasis	0.000236	0.00163	CcSEcCtD
Proguanil—Headache—Hydrocortisone—psoriasis	0.000234	0.00162	CcSEcCtD
Proguanil—DHFR—Cell Cycle, Mitotic—PTTG1—psoriasis	0.00023	0.00572	CbGpPWpGaD
Proguanil—Nervous system disorder—Methotrexate—psoriasis	0.000228	0.00158	CcSEcCtD
Proguanil—Gastrointestinal pain—Prednisone—psoriasis	0.000228	0.00158	CcSEcCtD
Proguanil—Nausea—Prednisolone—psoriasis	0.000227	0.00158	CcSEcCtD
Proguanil—Skin disorder—Methotrexate—psoriasis	0.000226	0.00156	CcSEcCtD
Proguanil—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000224	0.00558	CbGpPWpGaD
Proguanil—Vomiting—Triamcinolone—psoriasis	0.000224	0.00155	CcSEcCtD
Proguanil—Nausea—Hydrocortisone—psoriasis	0.000222	0.00154	CcSEcCtD
Proguanil—Rash—Triamcinolone—psoriasis	0.000222	0.00154	CcSEcCtD
Proguanil—Dermatitis—Triamcinolone—psoriasis	0.000222	0.00154	CcSEcCtD
Proguanil—Anorexia—Methotrexate—psoriasis	0.000222	0.00154	CcSEcCtD
Proguanil—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000221	0.0055	CbGpPWpGaD
Proguanil—Headache—Triamcinolone—psoriasis	0.000221	0.00153	CcSEcCtD
Proguanil—Abdominal pain—Prednisone—psoriasis	0.00022	0.00152	CcSEcCtD
Proguanil—Body temperature increased—Prednisone—psoriasis	0.00022	0.00152	CcSEcCtD
Proguanil—Diarrhoea—Betamethasone—psoriasis	0.000219	0.00151	CcSEcCtD
Proguanil—Diarrhoea—Dexamethasone—psoriasis	0.000219	0.00151	CcSEcCtD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000218	0.00543	CbGpPWpGaD
Proguanil—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000217	0.00541	CbGpPWpGaD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000216	0.00538	CbGpPWpGaD
Proguanil—Nausea—Triamcinolone—psoriasis	0.000209	0.00145	CcSEcCtD
Proguanil—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000206	0.00513	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—PTTG1—psoriasis	0.000206	0.00511	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000205	0.00509	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000203	0.00506	CbGpPWpGaD
Proguanil—Vomiting—Dexamethasone—psoriasis	0.000203	0.00141	CcSEcCtD
Proguanil—Vomiting—Betamethasone—psoriasis	0.000203	0.00141	CcSEcCtD
Proguanil—Decreased appetite—Methotrexate—psoriasis	0.000202	0.0014	CcSEcCtD
Proguanil—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000202	0.00502	CbGpPWpGaD
Proguanil—Rash—Dexamethasone—psoriasis	0.000201	0.0014	CcSEcCtD
Proguanil—Rash—Betamethasone—psoriasis	0.000201	0.0014	CcSEcCtD
Proguanil—Dermatitis—Betamethasone—psoriasis	0.000201	0.00139	CcSEcCtD
Proguanil—Dermatitis—Dexamethasone—psoriasis	0.000201	0.00139	CcSEcCtD
Proguanil—Gastrointestinal disorder—Methotrexate—psoriasis	0.000201	0.00139	CcSEcCtD
Proguanil—Headache—Betamethasone—psoriasis	0.0002	0.00139	CcSEcCtD
Proguanil—Headache—Dexamethasone—psoriasis	0.0002	0.00139	CcSEcCtD
Proguanil—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.0002	0.00498	CbGpPWpGaD
Proguanil—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000199	0.00495	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000195	0.00485	CbGpPWpGaD
Proguanil—Diarrhoea—Prednisone—psoriasis	0.00019	0.00132	CcSEcCtD
Proguanil—Gastrointestinal pain—Methotrexate—psoriasis	0.00019	0.00132	CcSEcCtD
Proguanil—Nausea—Dexamethasone—psoriasis	0.00019	0.00131	CcSEcCtD
Proguanil—Nausea—Betamethasone—psoriasis	0.00019	0.00131	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—TNF—psoriasis	0.000189	0.0047	CbGpPWpGaD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000186	0.00464	CbGpPWpGaD
Proguanil—Body temperature increased—Methotrexate—psoriasis	0.000184	0.00127	CcSEcCtD
Proguanil—Abdominal pain—Methotrexate—psoriasis	0.000184	0.00127	CcSEcCtD
Proguanil—Vomiting—Prednisone—psoriasis	0.000177	0.00123	CcSEcCtD
Proguanil—Rash—Prednisone—psoriasis	0.000175	0.00122	CcSEcCtD
Proguanil—Dermatitis—Prednisone—psoriasis	0.000175	0.00121	CcSEcCtD
Proguanil—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000175	0.00435	CbGpPWpGaD
Proguanil—Headache—Prednisone—psoriasis	0.000174	0.00121	CcSEcCtD
Proguanil—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000172	0.00429	CbGpPWpGaD
Proguanil—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000172	0.00428	CbGpPWpGaD
Proguanil—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000169	0.00422	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—TP53—psoriasis	0.000167	0.00414	CbGpPWpGaD
Proguanil—Nausea—Prednisone—psoriasis	0.000165	0.00114	CcSEcCtD
Proguanil—DHFR—Metabolism—NDUFA5—psoriasis	0.000164	0.00407	CbGpPWpGaD
Proguanil—Diarrhoea—Methotrexate—psoriasis	0.000159	0.0011	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—IL6—psoriasis	0.000152	0.00379	CbGpPWpGaD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000152	0.00378	CbGpPWpGaD
Proguanil—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000151	0.00375	CbGpPWpGaD
Proguanil—Vomiting—Methotrexate—psoriasis	0.000148	0.00102	CcSEcCtD
Proguanil—Rash—Methotrexate—psoriasis	0.000147	0.00102	CcSEcCtD
Proguanil—Dermatitis—Methotrexate—psoriasis	0.000146	0.00101	CcSEcCtD
Proguanil—Headache—Methotrexate—psoriasis	0.000146	0.00101	CcSEcCtD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000144	0.00358	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP2S1—psoriasis	0.000139	0.00346	CbGpPWpGaD
Proguanil—Nausea—Methotrexate—psoriasis	0.000138	0.000957	CcSEcCtD
Proguanil—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000135	0.00336	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000134	0.00332	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000133	0.00331	CbGpPWpGaD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00013	0.00323	CbGpPWpGaD
Proguanil—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000129	0.00322	CbGpPWpGaD
Proguanil—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.000119	0.00296	CbGpPWpGaD
Proguanil—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000116	0.0029	CbGpPWpGaD
Proguanil—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	0.000101	0.00251	CbGpPWpGaD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.0001	0.0025	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—PCNA—psoriasis	9.37e-05	0.00233	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—PCNA—psoriasis	8.38e-05	0.00208	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	8.37e-05	0.00208	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	7.24e-05	0.0018	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.97e-05	0.00173	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CARM1—psoriasis	6.79e-05	0.00169	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	6.32e-05	0.00157	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NDUFA5—psoriasis	5.85e-05	0.00145	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	5.42e-05	0.00135	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.42e-05	0.00135	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP2S1—psoriasis	4.97e-05	0.00124	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NDUFA5—psoriasis	4.51e-05	0.00112	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.21e-05	0.00105	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CAT—psoriasis	4.18e-05	0.00104	CbGpPWpGaD
Proguanil—DHFR—Disease—HLA-A—psoriasis	4.15e-05	0.00103	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NDUFA5—psoriasis	4.15e-05	0.00103	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NDUFA5—psoriasis	4.11e-05	0.00102	CbGpPWpGaD
Proguanil—DHFR—Disease—APOE—psoriasis	3.88e-05	0.000964	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP2S1—psoriasis	3.84e-05	0.000954	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.84e-05	0.000954	CbGpPWpGaD
Proguanil—DHFR—Disease—NOS2—psoriasis	3.61e-05	0.000899	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP2S1—psoriasis	3.53e-05	0.000878	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NDUFA5—psoriasis	3.52e-05	0.000875	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP2S1—psoriasis	3.5e-05	0.00087	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.28e-05	0.000816	CbGpPWpGaD
Proguanil—DHFR—Metabolism—APOE—psoriasis	3.25e-05	0.000808	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TP53—psoriasis	3.08e-05	0.000767	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP2S1—psoriasis	2.99e-05	0.000744	CbGpPWpGaD
Proguanil—DHFR—Disease—TYK2—psoriasis	2.96e-05	0.000736	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PPARG—psoriasis	2.83e-05	0.000703	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NDUFA5—psoriasis	2.71e-05	0.000675	CbGpPWpGaD
Proguanil—DHFR—Disease—CD4—psoriasis	2.68e-05	0.000666	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CARM1—psoriasis	2.43e-05	0.000604	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP2S1—psoriasis	2.31e-05	0.000574	CbGpPWpGaD
Proguanil—DHFR—Disease—STAT3—psoriasis	2.07e-05	0.000515	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.01e-05	0.0005	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CARM1—psoriasis	1.87e-05	0.000466	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.83e-05	0.000456	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.75e-05	0.000436	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CARM1—psoriasis	1.72e-05	0.000429	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CARM1—psoriasis	1.71e-05	0.000425	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.6e-05	0.000397	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.57e-05	0.00039	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CAT—psoriasis	1.49e-05	0.000372	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CARM1—psoriasis	1.46e-05	0.000363	CbGpPWpGaD
Proguanil—DHFR—Disease—IL6—psoriasis	1.45e-05	0.00036	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.36e-05	0.000339	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—APOE—psoriasis	1.16e-05	0.000289	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CAT—psoriasis	1.15e-05	0.000287	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CARM1—psoriasis	1.13e-05	0.00028	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CAT—psoriasis	1.06e-05	0.000264	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CAT—psoriasis	1.05e-05	0.000261	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PPARG—psoriasis	1.01e-05	0.000252	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CAT—psoriasis	8.98e-06	0.000223	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—APOE—psoriasis	8.95e-06	0.000223	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—APOE—psoriasis	8.23e-06	0.000205	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—APOE—psoriasis	8.16e-06	0.000203	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PPARG—psoriasis	7.8e-06	0.000194	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PPARG—psoriasis	7.17e-06	0.000178	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PPARG—psoriasis	7.11e-06	0.000177	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—APOE—psoriasis	6.98e-06	0.000174	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CAT—psoriasis	6.93e-06	0.000172	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PPARG—psoriasis	6.08e-06	0.000151	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—APOE—psoriasis	5.38e-06	0.000134	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PPARG—psoriasis	4.69e-06	0.000117	CbGpPWpGaD
